0000899243-21-008412.txt : 20210226
0000899243-21-008412.hdr.sgml : 20210226
20210226162348
ACCESSION NUMBER: 0000899243-21-008412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sperzel John J III
CENTRAL INDEX KEY: 0001602618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 21689239
MAIL ADDRESS:
STREET 1: 61 CRESTVIEW LANE
CITY: BRUNSWICK
STATE: ME
ZIP: 04011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0001492674
T2 Biosystems, Inc.
TTOO
0001602618
Sperzel John J III
101 HARTWELL AVENUE
LEXINGTON
MA
02421
1
1
0
0
See Remarks
Restricted Stock Units
2021-02-24
4
A
0
1693989
0.00
A
Common Stock
1693989
1693989
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units vest in three equal annual installments commencing on February 24, 2022.
President and Chief Executive Officer
/s/ John Sprague, Attorney-in-fact
2021-02-26